Shenzhen NeuroPlus Secures Seed Funding for Neuromodulation and Bioelectronic Medicine
Shenzhen NeuroPlus has reportedly raised “tens of millions” of renminbi in a seed financing round...
Deals
METiS Therapeutics In-Licenses Voronoi’s Pan-RAF Inhibitor Program
Cambridge, Massachusetts-based METiS Therapeutics has unveiled its first in-license deal, signing with South Korea’s Voronoi...
Immuno Cure BioTech Acquires Majority Stake in Shanghai Teresa Healthcare
Hong Kong-based Immuno Cure BioTech has announced the acquisition of a controlling 92.6% stake in...
Kamari Pharma Completes $8M Investment from Chinese Fund GIBF2
Israel-based Kamari Pharma has announced the completion of an $8 million investment from the Chinese...
Koutech Robotics Secures Series A Funding for Surgical Innovation
China-based Koutech Robotics (Shanghai) Co., Ltd, a leading ultra-micro, high-precision surgical robot platform company, has...
Joincare Pharmaceuticals Prices GDRs on SIX Swiss Exchange
China-based Joincare Pharmaceutical Group Industry Co., Ltd (SHA: 600380) has priced its Global Depository Receipts...
WuXi Biologics Partners with Elpiscience for Macromolecule Development
China-based Contract Research, Development, and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) has announced multiple...
Beijing Launches HIV Precision Medicine Standardization Project
On September 17, an HIV precision medicine standardization project was initiated in Beijing. The project,...
Fosun Pharma Signs Exclusive Licensing Deal for H008 with Carephar
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has signed an exclusive...
Suzhou Weiyou Gene Bio Raises Pre-Series A Funding for Gene Therapy Pipeline
China-based Suzhou View Gene Biotechnology Co., Ltd has reportedly raised “tens of millions” of renminbi...
Lepu Medtech Prices GDR Offering for International Expansion
China-based cardiovascular disease solutions provider Lepu Medical Technology (Beijing) Co., Ltd (SHE: 300003) has priced...
Zhong’ao Biopharmaceutical Secures Series A Funding for Cancer and HPV-Related Disease R&D
China-based Zhong’ao Biopharmaceutical Technology (Guangdong) Co., Ltd. has reportedly raised an undisclosed amount of money...
Ascletis Pharma and Roche Terminate Promotion Agreement for Pegasys
China-based Ascletis Pharma Inc. (HKG: 1672) has announced a supplementary agreement with Swiss pharmaceutical giant...
Apollomics Set to Merge with Maxpro Capital for Nasdaq Listing
Sino-US biotech Apollomics Inc. has revealed plans to merge with the special purpose acquisition company...
Shenzhen Vivolight Raises RMB 100 Million in Series D1 Financing for Laser Therapy Development
China-based laser diagnosis and treatment specialist Shenzhen Vivolight Medical Device & Technology Co., Ltd reportedly...
US Blocks Asymchem’s Acquisition of Snapdragon Chemistry
US authorities have intervened to block the purchase of US-based Contract Development and Manufacturing Organization...
Great Bay Bio Completes USD 15M Pre-Series B Financing to Advance AI Bioprocessing Platforms
Great Bay Bio (GBB), a Hong Kong-based biotechnology firm, announced the completion of a USD...
Zhonghong Pulin Partners with Shanghai Pharma for Logistics and Distribution
China-based Zhonghong Pulin Medical Product Co., Ltd (SHE: 300981) has entered into a partnership with...
Suzhou Jade Biomedical Secures USD 10 Million Series B Financing
China-based Suzhou Jade Biomedical Co., Ltd reportedly raised USD 10 million in a Series B...
Worg Pharmaceuticals Raises RMB 400 Million in Series B Funding
Worg Pharmaceuticals, a Hangzhou-based developer of novel allergic drugs, reportedly raised RMB 400 million (USD...